世界および日本の2019-nCoVアッセイ市場の洞察、2027年までの予測Global and Japan 2019-nCoV Assay Market Insights, Forecast to 2027 新冠状動脈性肺炎にかかっているかどうかを検出するための薬剤です。 市場分析とインサイト。世界と日本の2019-nCoVアッセイ市場 当レポートでは、世界と日本の2019-nCoVアッセイ市場に焦点を当てています。 ... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー新冠状動脈性肺炎にかかっているかどうかを検出するための薬剤です。市場分析とインサイト。世界と日本の2019-nCoVアッセイ市場 当レポートでは、世界と日本の2019-nCoVアッセイ市場に焦点を当てています。 2020年の世界の2019-nCoV Assay市場規模はXX百万米ドルで、2021-2027年の間にXX%のCAGRで、2027年末までにXX百万米ドルに達すると予想されています。日本では、2019-nCoVアッセイの市場規模は、2020年のXX百万米ドルから2027年にはXX百万米ドルまで、予測期間中にXX%のCAGRで成長すると予測されています。 2019-nCoVアッセイの世界規模の範囲と市場規模 2019-nCoV Assay市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。2019-nCoV Assayの世界市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2016年から2027年までの地域(国)別、タイプ別、アプリケーション別の売上高と予測に焦点を当てています。 日本市場では、2016年から2027年の期間で、2019-nCoVアッセイの市場規模を、プレイヤー別、タイプ別、アプリケーション別に取り上げています。主要プレイヤーには、日本で重要な役割を果たしているグローバルプレイヤーとローカルプレイヤーが含まれています。 タイプ別セグメント 核酸検出キット 抗体検出キット アプリケーション別 指定病院 診断センター 科学研究 ポートオブエントリー 個人 その他 地域別 北アメリカ 米国 カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア UAE 会社別 上海ZJバイオテック 上海Geneodx Biotech社 イノビータ Genomics Biotech (Wuhan) Zhongshan Daan Gene サナウレ 上海Bio-Germ 広州元宝生物技術有限公司 成都Boaojingバイオテック 北京XABT バイオサイエンス(重慶)バイオテック Maccuraバイオテック 厦門InnoDx 広東Hecin-Scientific 武漢Easydiagnosis Biomedicine Seegene PharmACT エバリーウェル Biopanda Mylab Discovery 目次1 Study Coverage1.1 2019-nCoV Assay Product Introduction 1.2 Market by Type 1.2.1 Global 2019-nCoV Assay Market Size Growth Rate by Type 1.2.2 Nucleic Acid Detection Kit 1.2.3 Antibody Detection Kit 1.3 Market by Application 1.3.1 Global 2019-nCoV Assay Market Size Growth Rate by Application 1.3.2 Designated Hospital 1.3.3 Diagnostic Center 1.3.4 Scientific Research 1.3.5 Port of Entry 1.3.6 Individual 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global 2019-nCoV Assay Market Size, Estimates and Forecasts 2.1.1 Global 2019-nCoV Assay Revenue 2016-2027 2.1.2 Global 2019-nCoV Assay Sales 2016-2027 2.2 Global 2019-nCoV Assay, Market Size by Region: 2016 VS 2021 VS 2027 2.3 2019-nCoV Assay Historical Market Size by Region (2016-2021) 2.3.1 Global 2019-nCoV Assay Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global 2019-nCoV Assay Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 2019-nCoV Assay Market Estimates and Projections by Region (2022-2027) 2.4.1 Global 2019-nCoV Assay Sales Forecast by Region (2022-2027) 2.4.2 Global 2019-nCoV Assay Revenue Forecast by Region (2022-2027) 3 Global 2019-nCoV Assay Competitor Landscape by Players 3.1 Global Top 2019-nCoV Assay Manufacturers by Sales 3.1.1 Global 2019-nCoV Assay Sales by Manufacturer (2016-2021) 3.1.2 Global 2019-nCoV Assay Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top 2019-nCoV Assay Manufacturers by Revenue 3.2.1 Key 2019-nCoV Assay Manufacturers Covered: Ranking by Revenue 3.2.2 Global 2019-nCoV Assay Revenue by Manufacturers (2016-2021) 3.2.3 Global 2019-nCoV Assay Revenue Share by Manufacturers (2016-2021) 3.2.4 Global 2019-nCoV Assay Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by 2019-nCoV Assay Revenue in 2020 3.2.6 Global 2019-nCoV Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global 2019-nCoV Assay Price by Manufacturers 3.4 Global 2019-nCoV Assay Manufacturing Base Distribution, Product Types 3.4.1 2019-nCoV Assay Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers 2019-nCoV Assay Product Type 3.4.3 Date of International Manufacturers Enter into 2019-nCoV Assay Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global 2019-nCoV Assay Market Size by Type (2016-2021) 4.1.1 Global 2019-nCoV Assay Sales by Type (2016-2021) 4.1.2 Global 2019-nCoV Assay Revenue by Type (2016-2021) 4.1.3 2019-nCoV Assay Average Selling Price (ASP) by Type (2016-2021) 4.2 Global 2019-nCoV Assay Market Size Forecast by Type (2022-2027) 4.2.1 Global 2019-nCoV Assay Sales Forecast by Type (2022-2027) 4.2.2 Global 2019-nCoV Assay Revenue Forecast by Type (2022-2027) 4.2.3 2019-nCoV Assay Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global 2019-nCoV Assay Market Size by Application (2016-2021) 5.1.1 Global 2019-nCoV Assay Sales by Application (2016-2021) 5.1.2 Global 2019-nCoV Assay Revenue by Application (2016-2021) 5.1.3 2019-nCoV Assay Price by Application (2016-2021) 5.2 2019-nCoV Assay Market Size Forecast by Application (2022-2027) 5.2.1 Global 2019-nCoV Assay Sales Forecast by Application (2022-2027) 5.2.2 Global 2019-nCoV Assay Revenue Forecast by Application (2022-2027) 5.2.3 Global 2019-nCoV Assay Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan 2019-nCoV Assay Market Size YoY Growth 2016-2027 6.1.1 Japan 2019-nCoV Assay Sales YoY Growth 2016-2027 6.1.2 Japan 2019-nCoV Assay Revenue YoY Growth 2016-2027 6.1.3 Japan 2019-nCoV Assay Market Share in Global Market 2016-2027 6.2 Japan 2019-nCoV Assay Market Size by Players (International and Local Players) 6.2.1 Japan Top 2019-nCoV Assay Players by Sales (2016-2021) 6.2.2 Japan Top 2019-nCoV Assay Players by Revenue (2016-2021) 6.3 Japan 2019-nCoV Assay Historic Market Review by Type (2016-2021) 6.3.1 Japan 2019-nCoV Assay Sales Market Share by Type (2016-2021) 6.3.2 Japan 2019-nCoV Assay Revenue Market Share by Type (2016-2021) 6.3.3 Japan 2019-nCoV Assay Price by Type (2016-2021) 6.4 Japan 2019-nCoV Assay Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan 2019-nCoV Assay Sales Forecast by Type (2022-2027) 6.4.2 Japan 2019-nCoV Assay Revenue Forecast by Type (2022-2027) 6.4.3 Japan 2019-nCoV Assay Price Forecast by Type (2022-2027) 6.5 Japan 2019-nCoV Assay Historic Market Review by Application (2016-2021) 6.5.1 Japan 2019-nCoV Assay Sales Market Share by Application (2016-2021) 6.5.2 Japan 2019-nCoV Assay Revenue Market Share by Application (2016-2021) 6.5.3 Japan 2019-nCoV Assay Price by Application (2016-2021) 6.6 Japan 2019-nCoV Assay Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan 2019-nCoV Assay Sales Forecast by Application (2022-2027) 6.6.2 Japan 2019-nCoV Assay Revenue Forecast by Application (2022-2027) 6.6.3 Japan 2019-nCoV Assay Price Forecast by Application (2022-2027) 7 North America 7.1 North America 2019-nCoV Assay Market Size YoY Growth 2016-2027 7.2 North America 2019-nCoV Assay Market Facts & Figures by Country 7.2.1 North America 2019-nCoV Assay Sales by Country (2016-2021) 7.2.2 North America 2019-nCoV Assay Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific 2019-nCoV Assay Market Size YoY Growth 2016-2027 8.2 Asia Pacific 2019-nCoV Assay Market Facts & Figures by Region 8.2.1 Asia Pacific 2019-nCoV Assay Sales by Region (2016-2021) 8.2.2 Asia Pacific 2019-nCoV Assay Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe 2019-nCoV Assay Market Size YoY Growth 2016-2027 9.2 Europe 2019-nCoV Assay Market Facts & Figures by Country 9.2.1 Europe 2019-nCoV Assay Sales by Country (2016-2021) 9.2.2 Europe 2019-nCoV Assay Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America 2019-nCoV Assay Market Size YoY Growth 2016-2027 10.2 Latin America 2019-nCoV Assay Market Facts & Figures by Country 10.2.1 Latin America 2019-nCoV Assay Sales by Country (2016-2021) 10.2.2 Latin America 2019-nCoV Assay Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa 2019-nCoV Assay Market Size YoY Growth 2016-2027 11.2 Middle East and Africa 2019-nCoV Assay Market Facts & Figures by Country 11.2.1 Middle East and Africa 2019-nCoV Assay Sales by Country (2016-2021) 11.2.2 Middle East and Africa 2019-nCoV Assay Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Shanghai ZJ Bio-Tech 12.1.1 Shanghai ZJ Bio-Tech Corporation Information 12.1.2 Shanghai ZJ Bio-Tech Description and Business Overview 12.1.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered 12.1.5 Shanghai ZJ Bio-Tech Recent Development 12.2 Shanghai Geneodx Biotech 12.2.1 Shanghai Geneodx Biotech Corporation Information 12.2.2 Shanghai Geneodx Biotech Description and Business Overview 12.2.3 Shanghai Geneodx Biotech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Shanghai Geneodx Biotech 2019-nCoV Assay Products Offered 12.2.5 Shanghai Geneodx Biotech Recent Development 12.3 INNOVITA 12.3.1 INNOVITA Corporation Information 12.3.2 INNOVITA Description and Business Overview 12.3.3 INNOVITA 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.3.4 INNOVITA 2019-nCoV Assay Products Offered 12.3.5 INNOVITA Recent Development 12.4 Genomics Biotech (Wuhan) 12.4.1 Genomics Biotech (Wuhan) Corporation Information 12.4.2 Genomics Biotech (Wuhan) Description and Business Overview 12.4.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Genomics Biotech (Wuhan) 2019-nCoV Assay Products Offered 12.4.5 Genomics Biotech (Wuhan) Recent Development 12.5 Zhongshan Daan Gene 12.5.1 Zhongshan Daan Gene Corporation Information 12.5.2 Zhongshan Daan Gene Description and Business Overview 12.5.3 Zhongshan Daan Gene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Zhongshan Daan Gene 2019-nCoV Assay Products Offered 12.5.5 Zhongshan Daan Gene Recent Development 12.6 Sanaure 12.6.1 Sanaure Corporation Information 12.6.2 Sanaure Description and Business Overview 12.6.3 Sanaure 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sanaure 2019-nCoV Assay Products Offered 12.6.5 Sanaure Recent Development 12.7 Shanghai Bio-Germ 12.7.1 Shanghai Bio-Germ Corporation Information 12.7.2 Shanghai Bio-Germ Description and Business Overview 12.7.3 Shanghai Bio-Germ 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Shanghai Bio-Germ 2019-nCoV Assay Products Offered 12.7.5 Shanghai Bio-Germ Recent Development 12.8 Guangzhou Wonfo Bio-Tech 12.8.1 Guangzhou Wonfo Bio-Tech Corporation Information 12.8.2 Guangzhou Wonfo Bio-Tech Description and Business Overview 12.8.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Products Offered 12.8.5 Guangzhou Wonfo Bio-Tech Recent Development 12.9 Chengdu Boaojing Bio-Tech 12.9.1 Chengdu Boaojing Bio-Tech Corporation Information 12.9.2 Chengdu Boaojing Bio-Tech Description and Business Overview 12.9.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Products Offered 12.9.5 Chengdu Boaojing Bio-Tech Recent Development 12.10 Beijing XABT 12.10.1 Beijing XABT Corporation Information 12.10.2 Beijing XABT Description and Business Overview 12.10.3 Beijing XABT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Beijing XABT 2019-nCoV Assay Products Offered 12.10.5 Beijing XABT Recent Development 12.11 Shanghai ZJ Bio-Tech 12.11.1 Shanghai ZJ Bio-Tech Corporation Information 12.11.2 Shanghai ZJ Bio-Tech Description and Business Overview 12.11.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered 12.11.5 Shanghai ZJ Bio-Tech Recent Development 12.12 Maccura Bio-Tech 12.12.1 Maccura Bio-Tech Corporation Information 12.12.2 Maccura Bio-Tech Description and Business Overview 12.12.3 Maccura Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Maccura Bio-Tech Products Offered 12.12.5 Maccura Bio-Tech Recent Development 12.13 Xiamen InnoDx 12.13.1 Xiamen InnoDx Corporation Information 12.13.2 Xiamen InnoDx Description and Business Overview 12.13.3 Xiamen InnoDx 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Xiamen InnoDx Products Offered 12.13.5 Xiamen InnoDx Recent Development 12.14 Guangdong Hecin-Scientific 12.14.1 Guangdong Hecin-Scientific Corporation Information 12.14.2 Guangdong Hecin-Scientific Description and Business Overview 12.14.3 Guangdong Hecin-Scientific 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Guangdong Hecin-Scientific Products Offered 12.14.5 Guangdong Hecin-Scientific Recent Development 12.15 Wuhan Easydiagnosis Biomedicine 12.15.1 Wuhan Easydiagnosis Biomedicine Corporation Information 12.15.2 Wuhan Easydiagnosis Biomedicine Description and Business Overview 12.15.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Wuhan Easydiagnosis Biomedicine Products Offered 12.15.5 Wuhan Easydiagnosis Biomedicine Recent Development 12.16 Seegene 12.16.1 Seegene Corporation Information 12.16.2 Seegene Description and Business Overview 12.16.3 Seegene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Seegene Products Offered 12.16.5 Seegene Recent Development 12.17 PharmACT 12.17.1 PharmACT Corporation Information 12.17.2 PharmACT Description and Business Overview 12.17.3 PharmACT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.17.4 PharmACT Products Offered 12.17.5 PharmACT Recent Development 12.18 Everlywell 12.18.1 Everlywell Corporation Information 12.18.2 Everlywell Description and Business Overview 12.18.3 Everlywell 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Everlywell Products Offered 12.18.5 Everlywell Recent Development 12.19 Biopanda 12.19.1 Biopanda Corporation Information 12.19.2 Biopanda Description and Business Overview 12.19.3 Biopanda 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Biopanda Products Offered 12.19.5 Biopanda Recent Development 12.20 Mylab Discovery 12.20.1 Mylab Discovery Corporation Information 12.20.2 Mylab Discovery Description and Business Overview 12.20.3 Mylab Discovery 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Mylab Discovery Products Offered 12.20.5 Mylab Discovery Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 2019-nCoV Assay Industry Trends 13.2 2019-nCoV Assay Market Drivers 13.3 2019-nCoV Assay Market Challenges 13.4 2019-nCoV Assay Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 2019-nCoV Assay Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
SummaryIt is an agent used to detect if you have new coronary pneumonia. Table of Contents1 Study Coverage1.1 2019-nCoV Assay Product Introduction 1.2 Market by Type 1.2.1 Global 2019-nCoV Assay Market Size Growth Rate by Type 1.2.2 Nucleic Acid Detection Kit 1.2.3 Antibody Detection Kit 1.3 Market by Application 1.3.1 Global 2019-nCoV Assay Market Size Growth Rate by Application 1.3.2 Designated Hospital 1.3.3 Diagnostic Center 1.3.4 Scientific Research 1.3.5 Port of Entry 1.3.6 Individual 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global 2019-nCoV Assay Market Size, Estimates and Forecasts 2.1.1 Global 2019-nCoV Assay Revenue 2016-2027 2.1.2 Global 2019-nCoV Assay Sales 2016-2027 2.2 Global 2019-nCoV Assay, Market Size by Region: 2016 VS 2021 VS 2027 2.3 2019-nCoV Assay Historical Market Size by Region (2016-2021) 2.3.1 Global 2019-nCoV Assay Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global 2019-nCoV Assay Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 2019-nCoV Assay Market Estimates and Projections by Region (2022-2027) 2.4.1 Global 2019-nCoV Assay Sales Forecast by Region (2022-2027) 2.4.2 Global 2019-nCoV Assay Revenue Forecast by Region (2022-2027) 3 Global 2019-nCoV Assay Competitor Landscape by Players 3.1 Global Top 2019-nCoV Assay Manufacturers by Sales 3.1.1 Global 2019-nCoV Assay Sales by Manufacturer (2016-2021) 3.1.2 Global 2019-nCoV Assay Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top 2019-nCoV Assay Manufacturers by Revenue 3.2.1 Key 2019-nCoV Assay Manufacturers Covered: Ranking by Revenue 3.2.2 Global 2019-nCoV Assay Revenue by Manufacturers (2016-2021) 3.2.3 Global 2019-nCoV Assay Revenue Share by Manufacturers (2016-2021) 3.2.4 Global 2019-nCoV Assay Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by 2019-nCoV Assay Revenue in 2020 3.2.6 Global 2019-nCoV Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global 2019-nCoV Assay Price by Manufacturers 3.4 Global 2019-nCoV Assay Manufacturing Base Distribution, Product Types 3.4.1 2019-nCoV Assay Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers 2019-nCoV Assay Product Type 3.4.3 Date of International Manufacturers Enter into 2019-nCoV Assay Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global 2019-nCoV Assay Market Size by Type (2016-2021) 4.1.1 Global 2019-nCoV Assay Sales by Type (2016-2021) 4.1.2 Global 2019-nCoV Assay Revenue by Type (2016-2021) 4.1.3 2019-nCoV Assay Average Selling Price (ASP) by Type (2016-2021) 4.2 Global 2019-nCoV Assay Market Size Forecast by Type (2022-2027) 4.2.1 Global 2019-nCoV Assay Sales Forecast by Type (2022-2027) 4.2.2 Global 2019-nCoV Assay Revenue Forecast by Type (2022-2027) 4.2.3 2019-nCoV Assay Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global 2019-nCoV Assay Market Size by Application (2016-2021) 5.1.1 Global 2019-nCoV Assay Sales by Application (2016-2021) 5.1.2 Global 2019-nCoV Assay Revenue by Application (2016-2021) 5.1.3 2019-nCoV Assay Price by Application (2016-2021) 5.2 2019-nCoV Assay Market Size Forecast by Application (2022-2027) 5.2.1 Global 2019-nCoV Assay Sales Forecast by Application (2022-2027) 5.2.2 Global 2019-nCoV Assay Revenue Forecast by Application (2022-2027) 5.2.3 Global 2019-nCoV Assay Price Forecast by Application (2022-2027) 6 Japan by Players, Type and Application 6.1 Japan 2019-nCoV Assay Market Size YoY Growth 2016-2027 6.1.1 Japan 2019-nCoV Assay Sales YoY Growth 2016-2027 6.1.2 Japan 2019-nCoV Assay Revenue YoY Growth 2016-2027 6.1.3 Japan 2019-nCoV Assay Market Share in Global Market 2016-2027 6.2 Japan 2019-nCoV Assay Market Size by Players (International and Local Players) 6.2.1 Japan Top 2019-nCoV Assay Players by Sales (2016-2021) 6.2.2 Japan Top 2019-nCoV Assay Players by Revenue (2016-2021) 6.3 Japan 2019-nCoV Assay Historic Market Review by Type (2016-2021) 6.3.1 Japan 2019-nCoV Assay Sales Market Share by Type (2016-2021) 6.3.2 Japan 2019-nCoV Assay Revenue Market Share by Type (2016-2021) 6.3.3 Japan 2019-nCoV Assay Price by Type (2016-2021) 6.4 Japan 2019-nCoV Assay Market Estimates and Forecasts by Type (2022-2027) 6.4.1 Japan 2019-nCoV Assay Sales Forecast by Type (2022-2027) 6.4.2 Japan 2019-nCoV Assay Revenue Forecast by Type (2022-2027) 6.4.3 Japan 2019-nCoV Assay Price Forecast by Type (2022-2027) 6.5 Japan 2019-nCoV Assay Historic Market Review by Application (2016-2021) 6.5.1 Japan 2019-nCoV Assay Sales Market Share by Application (2016-2021) 6.5.2 Japan 2019-nCoV Assay Revenue Market Share by Application (2016-2021) 6.5.3 Japan 2019-nCoV Assay Price by Application (2016-2021) 6.6 Japan 2019-nCoV Assay Market Estimates and Forecasts by Application (2022-2027) 6.6.1 Japan 2019-nCoV Assay Sales Forecast by Application (2022-2027) 6.6.2 Japan 2019-nCoV Assay Revenue Forecast by Application (2022-2027) 6.6.3 Japan 2019-nCoV Assay Price Forecast by Application (2022-2027) 7 North America 7.1 North America 2019-nCoV Assay Market Size YoY Growth 2016-2027 7.2 North America 2019-nCoV Assay Market Facts & Figures by Country 7.2.1 North America 2019-nCoV Assay Sales by Country (2016-2021) 7.2.2 North America 2019-nCoV Assay Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific 2019-nCoV Assay Market Size YoY Growth 2016-2027 8.2 Asia Pacific 2019-nCoV Assay Market Facts & Figures by Region 8.2.1 Asia Pacific 2019-nCoV Assay Sales by Region (2016-2021) 8.2.2 Asia Pacific 2019-nCoV Assay Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe 2019-nCoV Assay Market Size YoY Growth 2016-2027 9.2 Europe 2019-nCoV Assay Market Facts & Figures by Country 9.2.1 Europe 2019-nCoV Assay Sales by Country (2016-2021) 9.2.2 Europe 2019-nCoV Assay Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America 2019-nCoV Assay Market Size YoY Growth 2016-2027 10.2 Latin America 2019-nCoV Assay Market Facts & Figures by Country 10.2.1 Latin America 2019-nCoV Assay Sales by Country (2016-2021) 10.2.2 Latin America 2019-nCoV Assay Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa 2019-nCoV Assay Market Size YoY Growth 2016-2027 11.2 Middle East and Africa 2019-nCoV Assay Market Facts & Figures by Country 11.2.1 Middle East and Africa 2019-nCoV Assay Sales by Country (2016-2021) 11.2.2 Middle East and Africa 2019-nCoV Assay Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Shanghai ZJ Bio-Tech 12.1.1 Shanghai ZJ Bio-Tech Corporation Information 12.1.2 Shanghai ZJ Bio-Tech Description and Business Overview 12.1.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered 12.1.5 Shanghai ZJ Bio-Tech Recent Development 12.2 Shanghai Geneodx Biotech 12.2.1 Shanghai Geneodx Biotech Corporation Information 12.2.2 Shanghai Geneodx Biotech Description and Business Overview 12.2.3 Shanghai Geneodx Biotech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Shanghai Geneodx Biotech 2019-nCoV Assay Products Offered 12.2.5 Shanghai Geneodx Biotech Recent Development 12.3 INNOVITA 12.3.1 INNOVITA Corporation Information 12.3.2 INNOVITA Description and Business Overview 12.3.3 INNOVITA 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.3.4 INNOVITA 2019-nCoV Assay Products Offered 12.3.5 INNOVITA Recent Development 12.4 Genomics Biotech (Wuhan) 12.4.1 Genomics Biotech (Wuhan) Corporation Information 12.4.2 Genomics Biotech (Wuhan) Description and Business Overview 12.4.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Genomics Biotech (Wuhan) 2019-nCoV Assay Products Offered 12.4.5 Genomics Biotech (Wuhan) Recent Development 12.5 Zhongshan Daan Gene 12.5.1 Zhongshan Daan Gene Corporation Information 12.5.2 Zhongshan Daan Gene Description and Business Overview 12.5.3 Zhongshan Daan Gene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Zhongshan Daan Gene 2019-nCoV Assay Products Offered 12.5.5 Zhongshan Daan Gene Recent Development 12.6 Sanaure 12.6.1 Sanaure Corporation Information 12.6.2 Sanaure Description and Business Overview 12.6.3 Sanaure 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Sanaure 2019-nCoV Assay Products Offered 12.6.5 Sanaure Recent Development 12.7 Shanghai Bio-Germ 12.7.1 Shanghai Bio-Germ Corporation Information 12.7.2 Shanghai Bio-Germ Description and Business Overview 12.7.3 Shanghai Bio-Germ 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Shanghai Bio-Germ 2019-nCoV Assay Products Offered 12.7.5 Shanghai Bio-Germ Recent Development 12.8 Guangzhou Wonfo Bio-Tech 12.8.1 Guangzhou Wonfo Bio-Tech Corporation Information 12.8.2 Guangzhou Wonfo Bio-Tech Description and Business Overview 12.8.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Products Offered 12.8.5 Guangzhou Wonfo Bio-Tech Recent Development 12.9 Chengdu Boaojing Bio-Tech 12.9.1 Chengdu Boaojing Bio-Tech Corporation Information 12.9.2 Chengdu Boaojing Bio-Tech Description and Business Overview 12.9.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Products Offered 12.9.5 Chengdu Boaojing Bio-Tech Recent Development 12.10 Beijing XABT 12.10.1 Beijing XABT Corporation Information 12.10.2 Beijing XABT Description and Business Overview 12.10.3 Beijing XABT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Beijing XABT 2019-nCoV Assay Products Offered 12.10.5 Beijing XABT Recent Development 12.11 Shanghai ZJ Bio-Tech 12.11.1 Shanghai ZJ Bio-Tech Corporation Information 12.11.2 Shanghai ZJ Bio-Tech Description and Business Overview 12.11.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Shanghai ZJ Bio-Tech 2019-nCoV Assay Products Offered 12.11.5 Shanghai ZJ Bio-Tech Recent Development 12.12 Maccura Bio-Tech 12.12.1 Maccura Bio-Tech Corporation Information 12.12.2 Maccura Bio-Tech Description and Business Overview 12.12.3 Maccura Bio-Tech 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Maccura Bio-Tech Products Offered 12.12.5 Maccura Bio-Tech Recent Development 12.13 Xiamen InnoDx 12.13.1 Xiamen InnoDx Corporation Information 12.13.2 Xiamen InnoDx Description and Business Overview 12.13.3 Xiamen InnoDx 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Xiamen InnoDx Products Offered 12.13.5 Xiamen InnoDx Recent Development 12.14 Guangdong Hecin-Scientific 12.14.1 Guangdong Hecin-Scientific Corporation Information 12.14.2 Guangdong Hecin-Scientific Description and Business Overview 12.14.3 Guangdong Hecin-Scientific 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Guangdong Hecin-Scientific Products Offered 12.14.5 Guangdong Hecin-Scientific Recent Development 12.15 Wuhan Easydiagnosis Biomedicine 12.15.1 Wuhan Easydiagnosis Biomedicine Corporation Information 12.15.2 Wuhan Easydiagnosis Biomedicine Description and Business Overview 12.15.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Wuhan Easydiagnosis Biomedicine Products Offered 12.15.5 Wuhan Easydiagnosis Biomedicine Recent Development 12.16 Seegene 12.16.1 Seegene Corporation Information 12.16.2 Seegene Description and Business Overview 12.16.3 Seegene 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Seegene Products Offered 12.16.5 Seegene Recent Development 12.17 PharmACT 12.17.1 PharmACT Corporation Information 12.17.2 PharmACT Description and Business Overview 12.17.3 PharmACT 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.17.4 PharmACT Products Offered 12.17.5 PharmACT Recent Development 12.18 Everlywell 12.18.1 Everlywell Corporation Information 12.18.2 Everlywell Description and Business Overview 12.18.3 Everlywell 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Everlywell Products Offered 12.18.5 Everlywell Recent Development 12.19 Biopanda 12.19.1 Biopanda Corporation Information 12.19.2 Biopanda Description and Business Overview 12.19.3 Biopanda 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Biopanda Products Offered 12.19.5 Biopanda Recent Development 12.20 Mylab Discovery 12.20.1 Mylab Discovery Corporation Information 12.20.2 Mylab Discovery Description and Business Overview 12.20.3 Mylab Discovery 2019-nCoV Assay Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Mylab Discovery Products Offered 12.20.5 Mylab Discovery Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 2019-nCoV Assay Industry Trends 13.2 2019-nCoV Assay Market Drivers 13.3 2019-nCoV Assay Market Challenges 13.4 2019-nCoV Assay Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 2019-nCoV Assay Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
QYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(2019ncov)の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |